EMA
approval
· 2026-04-09
EMA Authorised: Sibnayal (potassium citrate monohydrated;potassium hydrogen carbonate) — Advicenne S.A.
Summary
The EMA authorised Sibnayal (potassium citrate monohydrated and potassium hydrogen carbonate) for renal tubular acidosis–related acidosis. The marketing authori…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Acidosis, Renal Tubular. MAH: Advicenne S.A.. Decision date: 09/04/2026